![Robert Whelan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Whelan
President chez
Whelan & Co. LLC
Profil
Robert M. Whelan occupe le poste de président d'Aspen Technology, Inc. et de président de Whelan & Co. LLC. Il est également membre du conseil d'administration d'iAnthus Capital Holdings, Inc. Auparavant, il a occupé les postes de directeur général chez Valuation Perspectives, Inc, directeur général et responsable des finances d'entreprise chez Hambrecht & Quist, Inc, président de Prudential Volpe Technology Group, directeur de l'exploitation de Volpe Brown Whelan & Co. LLC, MD-New York Regional & High Technology Groups chez Prudential Securities, membre du conseil d'administration de SVB Leerink LLC et directeur de Growth Capital Partners LP. Il a obtenu un diplôme de premier cycle au Dartmouth College et un MBA à la Stanford Graduate School of Business.
Postes actifs de Robert Whelan
| Sociétés | Poste | Début |
|---|---|---|
Whelan & Co. LLC | President | 01/01/2001 |
Vilua, Inc.
 Vilua, Inc. Information Technology ServicesTechnology Services Provides IT systems integration services | Directeur/Membre du Conseil | 01/01/2021 |
Anciens postes connus de Robert Whelan
| Sociétés | Poste | Fin |
|---|---|---|
| ASPEN TECHNOLOGY, INC. | Président | 12/03/2025 |
| ASPEN TECHNOLOGY | Président | 02/08/2021 |
| IANTHUS CAPITAL HOLDINGS, INC. | Directeur/Membre du Conseil | 18/01/2022 |
| ANNOVIS BIO, INC. | Directeur/Membre du Conseil | 14/03/2021 |
| ARIAD PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/09/2014 |
Formation de Robert Whelan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
36
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
AspenTech Corp.
 AspenTech Corp. Packaged SoftwareTechnology Services Operates as an asset management software company | Technology Services |
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
Prudential Securities
 Prudential Securities Investment Banks/BrokersFinance Provides brokerage services | Finance |
Growth Capital Partners LP
 Growth Capital Partners LP Investment ManagersFinance Growth Capital Partners LP (GCP) assists middle-market companies with private placements of equity or equity-related capital to fund internal growth and strategic acquisitions. All of the firm's activities are involved in the private equity marketplace. GCP does not divert resources to other activities such as sales and/or trading. The Southwest Mezzanine Fund I LP makes opportunistic investments in companies located in the Southwestern US. The firm invests across a variety of industries but does not invest in start-ups, turnarounds, real estate or oil & gas. Historically, GCP has invested in the energy, manufacturing, distribution, business services/staffing, consumer/retail, technology/software and healthcare. The Fund seeks to invest in companies with annual revenues of at least $15 million and a cash flow margin of at least 10%. GCP seeks to identify companies: (1) with experienced management teams (2) with proven stable cash flows (3) that operate in established industries (4) that possess a growing market share and (5) are unleveraged or low leveraged. Investments range from $2 million to $8 million and are structured as subordinated debt with a 3 to 5-year term, with current interest payable and equity participation for GCP. Coupon rates are 12% to 14%. GCP requires board observation rights. There are no penalties for prepayment and ownership ratchets are offered as incentives for early principal repayment. The Fund's capital is typically used for expansion capital, acquisition financing and recapitalizations. | Finance |
Annovis Bio, Inc.
 Annovis Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for Alzheimer's and Parkinson's diseases and other neurodegenerative disorders | Health Technology |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Leerink Partners LLC
 Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Prudential Volpe Technology Group
 Prudential Volpe Technology Group Investment Banks/BrokersFinance Provides brokerage services | Finance |
Volpe Brown Whelan & Co. LLC
 Volpe Brown Whelan & Co. LLC Investment Banks/BrokersFinance Investment firm | Finance |
Valuation Perspectives, Inc. | |
Whelan & Co. LLC | |
Stanford Graduate School of Business
 Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hambrecht & Quist, Inc.
 Hambrecht & Quist, Inc. Investment Banks/BrokersFinance Provides underwriting and investment services | Finance |
iAnthus Capital Holdings, Inc.
 iAnthus Capital Holdings, Inc. Agricultural Commodities/MillingProcess Industries Engages in cultivation, processing and dispensing of cannabis and cannabidiol products | Process Industries |
Vilua, Inc.
Vilua, Inc. Information Technology ServicesTechnology Services Provides IT systems integration services | Technology Services |
Aspen Technology, Inc.
 Aspen Technology, Inc. Packaged SoftwareTechnology Services Develops software for asset performance, monitoring management and optimization solutions | Technology Services |
